Razi Vaccine and Serum Research Institute: Razi Cov Pars

Razi Vaccine and Serum Research Institute: Razi Cov Pars

Vaccine Type: Protein Subunit

About Trial Phases

Phase 1: 1 Trial

IRCT20201214049709N1
Iran (Islamic Republic of)

Phase 2: 1 Trial

IRCT20201214049709N2
Iran (Islamic Republic of)

Phase 3: 1 Trial

IRCT20201214049709N3
Iran (Islamic Republic of)

Approvals

1 Country

Iran (Islamic Republic of)

Registered Trials

IRCT20201214049709N3
Phase 3
Iran (Islamic Republic of)
Total Enrollment: 41,128
Official Trial Registration:
- IRCT20201214049709N3(Opens in new tab/window)
IRCT20201214049709N2
Phase 2
Iran (Islamic Republic of)
Total Enrollment: 500
Official Trial Registration:
- IRCT20201214049709N2(Opens in new tab/window)
IRCT20201214049709N1
Phase 1
Iran (Islamic Republic of)
Total Enrollment: 133
Official Trial Registration:
- IRCT20201214049709N1(Opens in new tab/window)

© 2022 VIPER Group COVID19 Vaccine Tracker Team

Funding provided by the McGill University Interdisciplinary Initiative in Infection and Immunity (MI4)

This site is provided for informational purposes only based on publically available data.

Site Credits Website Feedback Form